EN DE

Dr MALLARD Joris

Fiche personne

coordonnées

ICANS | Institut cancérologie Strasbourg Europe
17 rue Albert Calmette
BP 23025
67033 STRASBOURG Cedex

03 68 76 74 19

j.mallard@icans.eu

Territoire

Alsace

Statut

Chercheur

affiliation

Institut de cancérologie Strasbourg Europe (ICANS)

Centre de recherche en biomédecine de Strasbourg (CRBS)

équipes/plateformes

Equipe Mitochondrie, stress oxydant et protection musculaire (MSP) - UR 3072

Recherche

Mots clés : muscle squelettique,cancer du sein,chimiothérapie,exercice,mitochondrie

Thématique de recherche :

Recherche en physiologie de l'exercice et physiologie cellulaire sur le déconditionnement et reconditionnement musculaire dans le cancer du sein traité par chimiothérapie

Publications

Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet.

Charlot A, Bringolf A, Mallard J, Charles AL, Niederhoffer N, Duteil D, Pagano AF, Geny B, Zoll J

Front Nutr. 2024 03 20;11:1366883

Changes in Macronutrients during Dieting Lead to Weight Cycling and Metabolic Complications in Mouse Model.

Charlot A, Bringolf A, Debrut L, Mallard J, Charles AL, Crouchet E, Duteil D, Geny B, Zoll J

Nutrients. 2024 02 25;16(5):

A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.

Mallard J, Hucteau E, Bender L, Moinard-Butot F, Rochelle E, Boutonnet L, Grandperrin A, Schott R, Pflumio C, Trensz P, Kalish-Weindling M, Charles AL, Gény B, Favret F, Pivot X, Hureau TJ, Pagano AF

J Cachexia Sarcopenia Muscle. 2024 01 6;:

Autologous mitochondrial transplantation in male mice as a strategy to prevent deleterious effects of peripheral ischemia-reperfusion.

Boutonnet L, Mallard J, Charles AL, Hucteau E, Geny B, Lejay A, Grandperrin A

Am J Physiol Cell Physiol. 2023 12 25;:

Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.

Gréa T, Jacquot G, Durand A, Mathieu C, Gasser A, Zhu C, Banerjee M, Hucteau E, Mallard J, Lopez Navarro P, Popescu BV, Thomas E, Kryza D, Sidi-Boumedine J, Ferrauto G, Gianolio E, Fleith G, Combet J, Brun S, Erb S, Cianferani S, Charbonnière LJ, Fellmann L, Mirjolet C, David L, Tillement O, Lux F, Harlepp S, Pivot X, Detappe A

Adv Mater. 2023 12 17;:e2308738

Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.

Hucteau E, Mallard J, Pivot X, Schott R, Pflumio C, Trensz P, Favret F, Pagano AF, Hureau TJ

Eur J Appl Physiol. 2023 03 20;:

Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.

Mallard J, Hucteau E, Schott R, Trensz P, Pflumio C, Kalish-Weindling M, Favret F, Pivot X, Hureau TJ, Pagano AF

Cancer. 2022 11 17;:

Development of skeletal muscle atrophy and intermuscular adipose tissue in early breast cancer patients treated with chemotherapy.

Mallard J, Hucteau E, Bender L, Charlot A, Debrut L, Pflumio C, Trensz P, Schott R, Favret F, Pivot X, Hureau TJ, Pagano AF

Am J Physiol Cell Physiol. 2022 09 12;:

Exercise-induced Fatigue in Hamstring versus Quadriceps Muscles and Consequences on the Torque-Duration Relationship in Men.

Massamba A, Hucteau E, Mallard J, Ducrocq GP, Favret F, Hureau TJ

Med Sci Sports Exerc. 2022 07 16;:

Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients.

Mallard J, Hucteau E, Charles AL, Bender L, Baeza C, Pélissie M, Trensz P, Pflumio C, Kalish-Weindling M, Gény B, Schott R, Favret F, Pivot X, Hureau TJ, Pagano AF

J Cachexia Sarcopenia Muscle. 2022 Apr 4;:

Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers.

Mallard J, Hucteau E, Hureau TJ, Pagano AF

Front Cell Dev Biol. 2021 09 14;9:719643

Identifying sex differences in neuromuscular fatigue: the challenge of normalizing exercise intensity and interpreting the results between populations.

Hureau TJ, Hucteau E, Massamba A, Mallard J, Ducrocq GP

J Physiol. 2021 06;599(11):2801-2802

Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol.

Mallard J, Hucteau E, Schott R, Petit T, Demarchi M, Belletier C, Ben Abdelghani M, Carinato H, Chiappa P, Fischbach C, Kalish-Weindling M, Bousinière A, Dufour S, Favret F, Pivot X, Hureau TJ, Pagano AF

Front Oncol. 2020 ;10:1304

C-Reactive Protein Level: A Key Predictive Marker of Cachexia in Lymphoma and Myeloma Patients.

Mallard J, Gagez AL, Baudinet C, Herbinet A, Maury J, Bernard PL, Cartron G

J Hematol. 2019 06;8(2):55-59